The rescue inhaler market comprises metered dose inhalers (MDIs) and dry powder inhalers (DPIs) used to treat sudden asthma attacks and provide immediate relief from symptoms of chronic obstructive pulmonary disease (COPD). Rescue inhalers work by quickly delivering asthma medication like albuterol to the lungs and providing relief within minutes. The global Rescue Inhaler Market is estimated to be valued at US$ 15.5 Bn in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing prevalence of chronic lung disorders such as asthma and COPD across the world has been a key factor in propelling the demand for rescue inhalers. As per the WHO, around 235 million people suffer from asthma globally with 1 in 12 people affected by it. Moreover, COPD is projected to become the third leading cause of death by 2030. Increasing pollution levels, growing elderly population, and rising cigarette smoking are some of the major causes responsible for the surge in chronic lung diseases. Subsequently, the spike in the diagnosis and treatment of such conditions has significantly boosted the rescue inhaler market over the recent years.
Strength: Rescue inhalers provide fast-acting relief for asthma attacks and COPD exacerbations. They are portable and easy to use.
Weakness: Overuse and dependency on rescue inhalers can worsen asthma control over time. Their effects are temporary and do not treat the underlying inflammation.
Opportunity: Expanding patient education programs can help improve inhaler technique and encourage appropriate escalation to maintenance therapies where underused.
Threats: Increasing development of digital health solutions and generic competition may erode brand loyalty and pricing flexibility over time.
The global rescue inhaler market is expected to witness high growth over the forecast period of 2023 to 2030. North America currently dominates the market due to high disease prevalence and medical awareness. However, Asia Pacific is expected to be the fastest growing region due to rising incomes, pollution levels and adaptation of Western lifestyles.
Regional analysis comprises: North America accounts for the largest share of the global rescue inhaler market currently owing to favourable reimbursement policies and healthcare infrastructure for respiratory diseases. However, Asia Pacific is poised to grow at the fastest pace during the forecast period supported by increasing healthcare expenditures, growing patient awareness and weak environmental regulations.
Key players related content comprises: Key players operating in the rescue inhaler market are GSK. Generic manufacturers also capture significant market share globally by providing low-cost alternatives. Leading players are focusing on expanding access through partnerships with local pharmacies and providers in developing regions with high unmet needs.
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it